Access cutting-edge atrial fibrillation treatment through this clinical trial at a research site in San Diego. Study-provided care at no cost to qualified participants.
Access atrial fibrillation specialists in San Diego at no cost
This study follows strict safety protocols and ethical guidelines
All study-related atrial fibrillation treatment provided free
REACT-AF is a multicenter prospective, randomized, open-label, blinded endpoint (PROBE design), controlled trial comparing the current Standard Of Care (SOC) of continuous Direct Oral Anticoagulation (DOAC) use versus time-delimited (1 month) DOAC guided by an AF-sensing Smart Watch (AFSW) in participants with a history of paroxysmal or persistent Atrial Fibrillation (AF) and low-to-moderate stroke risk.
Sponsor: Johns Hopkins University
Check if you qualify for this atrial fibrillation clinical trial in San Diego, CA
If you're searching for atrial fibrillation treatment options in San Diego, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our San Diego research site is actively enrolling participants for this clinical trial. You'll receive care from experienced atrial fibrillation specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.